###begin article-title 0
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 215 220 <span type="species:ncbi:9606">human</span>
Retinal degeneration (RD) is a complex mechanism that appears to involve many biologic processes including oxidative stress, apoptosis, and cellular remodeling. Currently there are 51 mapped, but not identified, RD human disease loci.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2,</italic>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 335 340 <span type="species:ncbi:9606">human</span>
To assign possible disease genes to RD loci, we have used a comparative genomics procedure that incorporates microarray gene expression data of three independent mouse models for photoreceptor dystrophy (rd1, rd2, and constant light-damage in BALB/c mice), human ortholog data, and databases of known chromosomal locations involved in human RD. Immunohistochemistry and enzyme activity assays were used to further characterize a candidate gene product.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLA2G7</italic>
###xml 614 617 614 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
Our analysis yielded candidate genes for four mapped, but unsolved, human chromosomal locations and confirmed two previously identified monogenic disease loci for human RD, thus validating our approach. PLA2G7 (phospholipase A2, group VII; PAF-AH, Lp-PLA2), a candidate for a dominant form macular dystrophy (Benign Concentric Annular Macular Dystrophy [BCMAD]), was selected for further study. The PLA2G7 enzyme is known to mediate breakdown of oxidatively damaged phospholipids, a contributor to oxidative stress in the retina. PLA2G7 protein was enriched in mouse photoreceptor inner and outer segments. In the rd1, rd2, and BALB/c mice exposed to constant light, retinal tissue activity levels, but not plasma levels, were significantly reduced at the onset of photoreceptor cell death.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 383 388 <span type="species:ncbi:9606">human</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 526 531 <span type="species:ncbi:9606">human</span>
We have shown that this comparative genomics approach verified existing RD genes as well as identified novel RD candidate genes. The results on the characterization of the PLA2G7 protein, one of the novel RD genes, suggests that retinal tissue PLA2G7 levels may constitute an important risk factor for BCMAD. In summary, this reverse mapping approach, using accepted mouse models of human disease and known human RD loci, may prove useful in identifying possible novel disease candidates for RD and may be applicable to other human diseases.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 682 689 <span type="species:ncbi:9606">patient</span>
The identification of genes and loci causing inherited retinal diseases such as retinitis pigmentosa (RP), macular degeneration (MD), and Usher (USH) syndrome are crucial for disease management [1]. Inherited retinal degeneration (RD) is the major cause of blindness in the developed world.  lists 28 different categories, and two complex forms of retinal disease, including 191 loci that have been mapped; the disease gene has been identified for 140 of these loci. While great strides have been made to identify genes and mutations causing these diseases, progress has been hampered by their enormous complexity, due to genetic, allelic, phenotypic, and clinical heterogeneity of patient populations [2]. For example, autosomal dominant RP has been associated with mutations in 16 genes and another locus with the gene yet to be determined; autosomal dominant macular degeneration has been associated with mutations in 14 genes and eight other loci; and autosomal recessive RP has been associated with mutations in 21 genes with five other loci. Thus, it is clear that there are a good number of existing RD loci for which the mutant genes are yet to be determined and, in addition, yet to be discovered new loci for various monogenic and complex RDs such as age-related macular degeneration (AMD) and diabetic retinopathy.
###end p 11
###begin p 12
###xml 580 583 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 736 737 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1126 1127 1126 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 456 461 <span type="species:ncbi:10090">mouse</span>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 1156 1161 <span type="species:ncbi:9606">human</span>
###xml 1401 1406 <span type="species:ncbi:9606">human</span>
We propose a technique to identify possible gene candidates for these human disease loci: gene expression analysis in mouse models of photoreceptor dystrophy. These analyses could identify genes that are misregulated during photoreceptor degeneration, correlating the human orthologs with chromosomal locations associated with inherited human retinal degeneration. Here we have followed this approach by using gene expression analysis from three unrelated mouse models of photoreceptor dystrophy. Two models match the human condition, as the same gene functions are affected (the rd1 and the rd2 mouse [3,4]) as well as a popular oxidative stress model thought to be relevant for diseases such as AMD (light-damage (LD) in albino mice [5]). The results are based on the premise that information collected about the orthologs of genes between species that exhibit the same trait or disease may be useful. Orthologs, by definition, evolved from the same gene, and usually share the same function. Correlating this information may provide evidence to determine a regulatory pattern of orthologs associated with congruent traits [6]. Genes that matched to the human RD loci and that were commonly up- or downregulated in all three models of degeneration are thought to be good candidates, especially if a literature search suggests that the known biologic information might be relevant to RD. Finally, as human retinal degenerations are usually caused by missense or nonsense mutations resulting in altered gene expression, the approach using expression differences to identify candidates is acceptable.
###end p 12
###begin p 13
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLA2G7</italic>
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1104 1106 1104 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
One of the genes, PLA2G7 (PAF-AH, Lp-PLA2), a candidate for a dominant form of macular dystrophy, benign concentric annular macular dystrophy (BCMAD), was selected for further study. The main function of platelet-activating factor (PAF) acetylhydrolase is to convert PAF into the biologically inactive lyso-PAF [7]. However, PLA2G7 also hydrolyzes oxidized phospholipids. Oxidized phospholipids are known to initiate cell death, triggering the intrinsic apoptotic caspase cascade [8]. Oxidative stress is activated in the photoreceptors of the three models of retinal degeneration studied herein [9] and is a contributing factor in AMD [10]. In addition, products generated by PLA2G7, lysophosphatidylcholine and oxidized nonesterified fatty acids, are thought to contribute to inflammation in atherosclerosis, coronary artery disease, and stroke [11]. Plasma PLA2G7 activity levels can be used in these diseases as a biomarker, while also functioning as an independent risk predictor for cardiovascular disease [12]. Finally, inflammation has been proposed as a possible driving force of AMD pathology [13-18].
###end p 13
###begin p 14
###xml 535 540 <span type="species:ncbi:10090">mouse</span>
###xml 854 859 <span type="species:ncbi:9606">human</span>
The reverse-mapping approach identified possible novel disease candidates for RD, which are discussed in the context of their known gene function and possible involvement in disease pathology. Of the identified candidate genes, two of them were previously confirmed to be the disease genes in loci associated with photoreceptor degeneration, supporting the validity of our approach while four additional genes were novel candidates for three mapped RD chromosomal loci. One of the candidate gene products, Pla2g7, was localized to the mouse photoreceptor inner and outer segments, and retinal tissue activity levels were significantly reduced before photoreceptor cell death. Hence, this tactic has resulted in the identification of novel candidates for three RD loci and demonstrated this as a feasible approach to identifying gene candidates for other human diseases as well.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 13 15 13 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 26 27 26 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 808 809 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
C57BL/6 rd1 [19] and rd2 [4] mice were gifts from Drs. Debora Farber and Gabriel Travis (both at University of California, Los Angeles, CA). Both strains were maintained as homozygotes. C57BL/6 and BALB/c mice were generated from breeding pairs obtained from Harlan Laboratories (Indianapolis, IN). Animals were housed in the Medical University of South Carolina (MUSC) Animal Care Facility under a 12 h:12 h light-dark cycle with access to food and water ad libitum. The ambient light intensity at the eye level of the animals was 85+/-18 lux. Light damage was produced by exposing the BALB/c animals to constant fluorescent light for 24 or 48 h at an illuminance of approximately 1500 lux. This intensity reduces the number of photoreceptors to 50% within 10 days in 3-month-old (young adult) albino mice [5]. All experiments were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the University Animal Care and Use Committee.
###end p 17
###begin title 18
Microarray analyses
###end title 18
###begin title 19
Samples
###end title 19
###begin p 20
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 795 798 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1152 1153 1152 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 429 434 <span type="species:ncbi:10090">mouse</span>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 799 804 <span type="species:ncbi:10090">mouse</span>
Affymetrix oligonucleotide (MGU74AV2) arrays (Affymetrix Inc, Santa Clara, CA), containing 12489 genes and ESTs, were used for this analysis as described previously [20]. The Affymetrix CEL files, containing the raw intensity values, were used for expression data analysis. To determine genes that could be potential candidates for retina-specific chromosomal locations, we compared gene expression data from the three unrelated mouse models of photoreceptor dystrophy. To analyze genes involved in neurodegeneration, we argued that genes altered early in the progression would be involved in initiating degeneration. For the rd1 mouse, we collected retinas from days P6 and P10, which represent early time points during which cGMP continues to rise [3] and apoptosis is initiated [21]; for the rd2 mouse, we collected retinas from P14 and P21, representing early time points during the first phase of apoptosis [21]; and finally for the light-damaged paradigm, we collected retinas 24 and 48 h after the onset of constant light at 1500 lux, a point at which a few TUNEL-positive photoreceptors can be observed, but no cell loss can yet be documented [9].
###end p 20
###begin title 21
RNA isolation
###end title 21
###begin p 22
###xml 542 544 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 545 547 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 752 754 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
All chemicals used in this study were at least molecular biology grade material and purchased from Fisher Scientific (Pittsburgh, PA), unless otherwise noted. Animals (see Samples for ages of animals) were sacrificed by decapitation and retinas isolated and stored in RNA-later (Ambion, Austin, TX) at -20 degreesC. Retinas from four animals per genotype per time point were pooled, and each data point was obtained in duplicate. Pooling is recommended as the method of choice to reduce the number of arrays needed to generate reliable data [20,22]. Total RNA was isolated using Trizol (Ambion), followed by a clean-up using RNAeasy minicolumns (Qiagen, Valencia, CA). The quality of the RNA was examined by gel electrophoresis, and spectrophotometry [20].
###end p 22
###begin title 23
Microarray procedures
###end title 23
###begin p 24
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
Sample preparation and hybridization was performed as described in the Affymetrix Expression Analysis Technical Manual and published previously [20]. In short, double-stranded cDNA was generated (SuperScripttrade mark II Reverse Transcriptase; Invitrogen, Carlsbad, CA) using 5 mug total RNA as starting material, and purified using phase-lock gel columns (Eppendorf, Westbury, NY) followed by ethanol precipitation. The purified cDNA served as a template for the generation of biotinylated cRNA, using the BioArraytrade mark HighYieldtrade mark RNA transcript labeling kit (Enzo Diagnostics, New York, NY). Labeled probes were purified using the RNEasy mini kit (Qiagen, Valencia, CA), fragmented by metal-induced hydrolysis at 94 degreesC for 35 min (100 mM potassium acetate, 30 mM magnesium acetate, and 40 mM tris-acetate) and stored at -80 masculineC. The length of the cRNA and fragmentation was confirmed by agarose gel electrophoresis. Hybridization with equal amounts of labeled cRNA (15 microg/array) and readout was performed by the DNA Microarray Core Facility at MUSC, using the Affymetrix Fluidics Station.
###end p 24
###begin title 25
Data analysis
###end title 25
###begin title 26
Normalization and filtering
###end title 26
###begin p 27
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
Genechips were scanned using the Affymetrix scanner (Microarray Suite 5.0 software) to obtain probe level data. Outputs were scaled to the same target intensity. The raw Affymetrix data (absolute expression level and perfect match (PM)-values) was used for normalization. Each of the three model sets were normalized using quantile normalization on the probe and probe set level. This procedure was done using  software [23]. Gene filtering was performed individually on the three retinal degeneration sets. Normalized data was filtered on significant p-values (</=0.05) in fold change and difference of the means between experimental and age-matched control samples (value of >/=100). With an estimated median expression level of 90 this automatically excludes low-expressing genes.  was used to identify genes that localized to RD loci.
###end p 27
###begin title 28
Analysis of retinal degeneration chromosomal loci
###end title 28
###begin p 29
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
###xml 233 238 <span type="species:ncbi:9606">human</span>
###xml 331 336 <span type="species:ncbi:9606">human</span>
###xml 384 389 <span type="species:ncbi:9606">human</span>
For us to be able to match the differentially expressed mouse genes to known chromosomal locations involved in retinal degeneration, we needed human orthologs to these mouse genes. The  NetAffx Analysis Center was used to obtain the human orthologs, as well as accession numbers and chromosome locations for all genes. The list of human ortholog locations was correlated with the 191 human retina-specific locations currently listed in , to determine which locations were unknown and unsolved.
###end p 29
###begin title 30
Gene ranking and probability
###end title 30
###begin p 31
To determine the probability of one of the genes in our analysis falling into one of the retina-related loci, we implemented an algorithm using the gene lengths, locus lengths, and chromosome lengths. Probability was determined by calculating the ratio of gene length to locus length over the ratio of the gene length to chromosome length. Genes were ranked based on a combined score of probability: 5 (0%-4.9%), 4 (5%-9.9%), 3 (10%-14.9%), 2 (15%-19.9%), 1 (20%-above). This score was multiplied by the number of models in which the genes were differentially expressed (3, 2, or 1), resulting in a maximum score of 15.
###end p 31
###begin title 32
Gene ontology analysis
###end title 32
###begin p 33
Gene Ontology (GO) analysis on the identified genes was done using  by Tim Beissbarth. GO p-values were computed, and the GO terms with significant p-values identified to compile the final list of overrepresented GO terms. All ontologies (Molecular Function, Biologic Process, and Cellular Component) were analyzed as a group.
###end p 33
###begin title 34
Pla2g7 analysis
###end title 34
###begin title 35
Immunohistochemistry
###end title 35
###begin p 36
###xml 268 270 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 630 633 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
For immunohistochemical analysis, eyes were fixed in 4% paraformaldehyde, rinsed, cryoprotected in 30% sucrose overnight, frozen in TissueTek O.C.T. (Fisher Scientific) and cut into 14 mum cryostat sections. Immunohistochemistry was performed as described previously [24] using an anti-PAF-AH antibody (Lis-1; Abcam, Cambridge, MA) at 1:100. For visualization, a fluorescent-labeled secondary antibody (Alexa 488; Invitrogen, Carlsbad, CA) was used. Each staining was performed on slides from at least three animals per condition. Sections were examined by fluorescence microscopy (Zeiss) and images were false-colored using Adobe(R) Photoshop (Adobe Systems, San Jose, CA).
###end p 36
###begin title 37
Activity assay
###end title 37
###begin p 38
###xml 540 545 <span type="species:ncbi:9606">human</span>
PLA2G7 is known to catalyze the hydrolysis of the substrate platelet-activating factor (PAF) into the biologically inactive lyso-PAF. The assay (Cayman Chemical, Ann Arbor, MI) uses 2-thio PAF as a substrate for PAF-AH. Hydrolysis produces free thiols, reacting it with an excess of 5,5'-dithio-bis-2-nitrobenzoic acid (DTNB); which is measured spectrometrically. Neither the substrate nor the lyso-PAF react with DTNB. As a negative control the enzyme source (plasma or retina) is heat-inactivated for 15 min and used with the substrates; human PLA2G7 provided in the kit was taken as positive control for all the measurements. The commercial kit was used according to the manufacturer's recommendations.
###end p 38
###begin p 39
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
For tissue levels, retinas were dissected out from eyes of rd1 (P10), rd2 (P21), and 48 h light-damaged BALB/c mice and corresponding control animals. Retinas were homogenized in 100 mul of cold Tris-Cl buffer (0.1 M, pH 7.2) and centrifuged at 10,000x g for 15 min at 4 degreesC. Supernatants were collected and total protein content in each sample assayed by the Bradford method. To determine plasma levels, blood was collected from the submandibular vein in isoflurane anesthetized mice. The vein was punctured with a 22 gauge needle, which initiates blood flow and sample collected with a pipette using citrate as an anticoagulant (0.38% final concentration). Plasma samples were collected after centrifugation (800x g for 10 min at 4 degreesC).
###end p 39
###begin p 40
The assay-mixtures each contained 10 mul of sample, to which 5 mul of assay buffer was added to each well of a 96 well flat-bottom plate. Reaction in each well was initiated by adding 200 mul of substrate solution (2-thio PAF). Following incubation at room temperature (30 min for retina, 1 min for plasma), 10 mul of DTNB was added to each well. Color development was measured in a spectrophotometer (Softmax; Molecular Devices, Sunnyvale, CA) at 405 nm, 1 min after the addition of DTNB. Specific activity of PLA2G7 was calculated from the absorbance values (extinction coefficient for DTNB at 405 nm, 12.8/mM/cm). Data are expressed as mean+/-SE of at least three independent Pla2g7 activity measurements in units of specific activity for tissue [mumol/minute/mg of protein] or plasma [mumol/minute/ml of plasma].
###end p 40
###begin title 41
Results
###end title 41
###begin title 42
Identification of candidate genes
###end title 42
###begin p 43
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
The  database currently lists 191 retina-specific human loci: 140 of the human disease loci are mapped and the disease gene identified, leaving 51 of the human loci uncharacterized (see ). By correlating the nucleotide position data for each of these unknown locations with those of the 12489 genes and ESTs present on the MGU74Av2 array and their orthologs, we have the potential to identify candidate genes for 37 of these unsolved disease loci (approximately 73%).
###end p 43
###begin p 44
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
Mapped but unidentified chromosomal disease loci are typically large, some spanning many cM, and harbor upwards of hundreds of genes. For example, the 37 RD loci for which genes matched in the MGU74Av2 array range in size from 1.8 to 49.2 Mbp (median size: 16.71 Mbp). The average number of genes contained within a location of 16.71 Mbp is 393.18, based on an average gene density of 40-45 kb [25]. Identifying potential candidates requires additional search criteria. Underlying an identification of a mapped locus are genetic differences influencing the susceptibility to a trait or disease. Thus, here we argued that these presumed genetic differences should be reflected in the difference in retinal gene expression of mice with RD.
###end p 44
###begin p 45
###xml 154 157 154 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 1059 1066 1057 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1601 1608 1599 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
###xml 344 349 <span type="species:ncbi:10090">mouse</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
###xml 485 490 <span type="species:ncbi:10090">mouse</span>
###xml 992 997 <span type="species:ncbi:9606">human</span>
###xml 1031 1036 <span type="species:ncbi:9606">human</span>
###xml 1309 1314 <span type="species:ncbi:9606">human</span>
To analyze differences in gene expression related to photoreceptor degeneration, we selected three unrelated mouse models of photoreceptor dystrophy: the rd1 mouse (calcium overload) [26]; the rd2 mouse (structural defect due to a mutation in the disc rim protein peripherin); and constant light-damage (LD; oxidative stress) [3,5,27]. The rd1 mouse is considered a model for RP, whereas the rd2 mouse and the LD model are used as models for both RP and macular degeneration. For each mouse model, we determined changes in gene expression between the experimental animals and their age-matched controls at two consecutive time points early in the progression of degeneration. For a given gene to be considered as a possible candidate or a retina-specific location, it had to be significantly up- or downregulated (p<0.05) with a predefined mean difference in expression level (>/=100) in at least one of the three models. Of the 902 genes that met these criteria, 20 genes were found to have human orthologs that were localized to human retinal degeneration (Table 1). Experimental data regarding gene expression levels and fold differences in gene expression () are provided in the supplemental material section. These 20 genes were ranked on two criteria: (a) based on their probability of falling within a human disease locus by chance; (b) multiplied by the number of models in which the genes were differentially expressed. Due to the significant difference in locus size for the different diseases (i.e., the 20 loci range in size from 1.7 to 60 Mbp), the probability ranged from 1.9% to 46.9% (Table 2, column 5), with the median probability of 6.6%.
###end p 45
###begin title 46
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
Genes corresponding to human disease loci identified by being either commonly up- or down-regulated in three, independent mouse models of photoreceptor dystrophy.
###end title 46
###begin p 47
###xml 759 766 759 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 771 778 771 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 205 210 <span type="species:ncbi:10090">mouse</span>
###xml 233 238 <span type="species:ncbi:10090">mouse</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
The highlighted gene symbols (column 3) represent the mapped, but unsolved loci (column 7), the remaining genes localize to loci that have already been solved. The genes are documented with respect to the mouse gene name, symbol and mouse transcript ID (columns 2-4) and their human ortholog (column 5). Column 6 provides information about the chromosomal location of the human ortholog; column 7 lists the name(s) of the loci. Please note that in some entries in the locus column, there are multiple names given, meaning that more than one trait resides in that chromosomal location; however these may or may not be related. Column 1, the Affymetrix Gene ID; and column 3, the gene symbol; represent the common denominators for all Tables in the manuscript (Table 1 and Table 2) and  and .
###end p 47
###begin title 48
###xml 55 60 <span type="species:ncbi:9606">human</span>
Characterization of genes identified as candidates for human disease loci.
###end title 48
###begin p 49
###xml 106 113 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 708 709 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
Genes are identified by Affymetrix Gene ID (column 1) and gene symbol (column 2) for easy comparison with Table 1. Column 3 identifies the type of misregulation (up- or down-regulated) and column 4 documents in which animal models the misregulation occurs. The probability of each gene to fall within the respective locus is listed in column 5; this probability multiplied by the number of models in which the genes are differentially expressed (3, 2, or 1) produced a gene ranking score (maximum column 6). The remaining columns document whether the respective gene is present in photoreceptors based on the retina SAGE library (column 7: x, present; -, absent; ?, no data available; *confirmed by qRT-PCR [9]), whether the gene is misregulated in retina injury models (column 8; identified by +) or after bright light exposure (column 9; identified by +), or which genes were found to cluster together (eye database at ; column 10; 3 clusters, 1-3 were identified, as well as three unclustered genes).
###end p 49
###begin title 50
Gene ontology analysis of identified genes
###end title 50
###begin p 51
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 456 463 456 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
To gain biologic understanding from the identified genes found in unsolved chromosomal locations (Table 1), we analyzed their functional annotations. GO identifications (GO IDs) and GO terms were retrieved for all significant ontologies (Biologic Process, Molecular Function, and Cellular Compartment). The GO terms associated with the 20 identified genes were compared to those of the reference group (all genes present on the array minus those listed in Table 1), determining significantly over-represented terms and obtaining important GO terms that describe these differentially regulated genes. The significantly overrepresented GO terms that were retrieved for the upregulated genes included the terms "defense response," "immune response," and "complement activation," whereas in the downregulated genes, the terms identified the keywords "positive gene regulation of rhodopsin," "retinal rod cell development," and "thioredoxin peroxidase activity" ().
###end p 51
###begin title 52
Pla2g7 in retinal degeneration
###end title 52
###begin p 53
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 265 268 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 412 421 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 329 334 <span type="species:ncbi:10090">mouse</span>
Pla2g7 (PAF-AH, Lp-PLA2), a possible candidate for a dominant form of macular dystrophy (BCMAD), was selected for further study. Pla2g7 mRNA levels are significantly down-regulated in P10 rd1 [fold difference (lower bound; upper bound)] [-1.39 (-1.26; -1.54)], P21 rd2 [-4.5 (-3.5; -5.55)] and 48 h of light-damage in the BALB/c mouse retina [-2.37 (-1.57; -4.7)], which is before significant cell loss [9] (see Figure 1A). Pla2g7 localization in ocular tissues and PAF-AH activity levels in plasma and retina tissue were investigated.
###end p 53
###begin p 54
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2,</italic>
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 157 163 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 371 372 369 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 763 764 758 759 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 865 868 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 873 876 868 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
Pla2g7 mRNA and activity levels, analyzing levels from P10 rd1, P21 rd2, and 48 h light-exposed BALB/c animals and their respective age-matched controls. A: Pla2g7 mRNA levels were plotted from . Retina Pla2g7 mRNA levels are significantly reduced in all three genotypes when compared to controls. Data are expressed as mean+/-SD of the two arrays analyzed per genotype. B: Tissue retina Pla2g7 levels as measured in a calorimetric assay using 2-thio platelet activating factor (PAF) as substrate, revealed that activity levels in retinas from the three genotypes correlated well with the respective reduced amount of mRNA found in the tissue. Data are expressed as mean+/-SEM of at least three, independent samples in unit of activity (mumol/min/mg of protein). C: Plasma Pla2g7 levels measured in mandibular blood samples revealed that the two genetic mutations (rd1 and rd2) or the environmental stress (constant light) did not influence systemic, plasma-derived Pla2g7 activity. Data are expressed as mean+/-SEM of at least three independent samples in unit of activity (mumol/min/mL of plasma). In the graph, red indicates control and blue indicates experimental. The following abbreviations were used: light-damage (LD) and not significant (n.s.)
###end p 54
###begin p 55
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 290 298 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Pla2g7 is a gene highly enriched in the mouse retina according to the ; in the retina, Pla2g7 mRNA is present in the outer nuclear layer (ONL) that contains only the cell bodies with the nuclei of rods and cones (retina ) [28]. Immunohistochemistry revealed labeling in the photoreceptors (Figure 2), in particular the inner and outer segments, with additional labeling in the outer and inner plexiform layer, as well as staining of cells in the inner retina.
###end p 55
###begin p 56
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 165 166 165 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 796 797 796 797 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
Pla2g7 localization. Immunohistochemistry was performed in juvenile C57BL/6 (P17) frozen sections (A), using no primary antibody conditions as the negative control (B). Pla2g7 was found to be localized throughout the retina. Relatively elevated levels were found in the photoreceptor inner and outer segments, whereas moderate staining was found in the two plexiform layers, as well as the inner nuclear layer (INL) and the retinal ganglion cell (RGC) layer. For each image, the corresponding DIC image is provided. The following abbreviations were used: retinal pigment epithelium (RPE), outer segments (OS), inner segments (IS), outer nuclear layer (ONL), outer plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL), and RGC: retinal ganglion cells (RGC). Scale bar in (A) represents 20 mum.
###end p 56
###begin p 57
###xml 74 85 74 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B,C</xref>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 213 222 213 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 394 396 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 419 422 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 445 447 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 473 476 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 722 725 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 750 753 737 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 805 812 792 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 842 848 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
Pla2g7 activity was compared in soluble extracts of retina and in plasma (Figure 1B,C). Serum levels of Pla2g7 activity were not affected by RD triggered by either genetic (rd1, rd2) or environmental insults (LD; Figure 1C). Plasma levels in the P10, C57BL/6 wild-type mouse were higher than that obtained at P21, but not different from rd1 at P10 nor rd2 at P21 ([in mumol/min/ml plasma] P10: wt, 0.093+/-0.013 versus rd1, 0.091+/-0.0058; P21: wt, 0.0367+/-0.00009 versus rd2, 0.0387+/-0.0012). Likewise, no difference was identified in light-damaged BALB/c retina (cyclic light, 0.0935+/-0.005 versus LD, 0.0913+/-0.006). When compared to their respective age-matched controls, Pla2g7 levels were reduced by ~30% in the rd1 retinas, by ~70% in the rd2 retinas, and by ~50% in the light-damaged retinas (Table 3). Relative changes in retina Pla2g7 mRNA levels were a good predictor of retina cytosolic Pla2g7 activity levels.
###end p 57
###begin title 58
Enzyme activity for Pla2g7 in retinal degeneration
###end title 58
###begin p 59
###xml 113 116 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 122 125 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
Quantification of specific activity of Pla2g7 [mumol/minute/mg of protein] in retina extracts collected from P10 rd1, P21 rd2 mice, and 3-month old BALB/c mice after 24 h of light damage (column 2), together with their age-matched controls (column 3). Cytosolic levels of Pla2g7 were significantly reduced (column 4) in all three models of photoreceptor degeneration. Data is expressed as mean+/-SEM for 3-5 samples per condition.
###end p 59
###begin title 60
Discussion
###end title 60
###begin title 61
Comparative genomics analysis to identify novel disease genes
###end title 61
###begin p 62
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
RD-causing mutations are found in genes whose proteins participate typically in one of four mechanisms: outer segment morphogenesis, cellular metabolism, function of the retinal pigment epithelium, and the photoreceptor signal transduction cascade [29]. However, other genes that are not typical photoreceptor-specific genes have been identified to have mutations in inherited RD, which include mutations in components of the alternative complement pathway (part of the body's innate immune system) that have been shown to be associated with AMD [14,16-18]. Hence, we used a comparative genomics approach to aid in the identification of potentially novel disease genes.
###end p 62
###begin p 63
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 147 152 <span type="species:ncbi:9606">human</span>
###xml 637 642 <span type="species:ncbi:10090">mouse</span>
Herein we have used gene expression analysis in three independent models of photoreceptor dystrophy, which showed key pathologies also seen in the human conditions, to identify novel candidates for gene loci known to be associated with inherited retinal diseases. While it would have been beneficial to obtain retina-specific arrays for our analysis, the U74Av2 arrays used had a present rate (i.e., genes that are expressed in the retina) of >50%, representing >6000 genes/ESTs. These 6,000 elements cover an estimated 50% of the 13k mammalian retinal transcriptome, as defined by Schulz and colleagues [30] or approximately 62% of the mouse retinal transcriptome identified by Blackshaw and coworkers [28]. Thus, our proposed "fishing expedition" still presents tremendous advantages when compared with a hypothesis-driven data analysis that investigates one gene at a time, but will likely miss roughly 50% of potential candidates.
###end p 63
###begin p 64
###xml 785 792 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 840 846 840 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnb1</italic>
###xml 854 862 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pde6&#946;</italic>
###xml 864 867 861 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vtn</italic>
###xml 873 876 870 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nrl</italic>
###xml 902 905 899 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fos</italic>
###xml 907 911 904 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Egr1</italic>
###xml 917 926 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebp&#948;</italic>
###xml 967 972 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-D2</italic>
###xml 974 981 967 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#946;</italic>
###xml 983 987 973 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1qc</italic>
###xml 989 993 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-K</italic>
###xml 995 1003 985 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#945;</italic>
###xml 1005 1007 991 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C4</italic>
###xml 1009 1015 995 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-T23</italic>
###xml 1017 1024 1003 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isgf3g,</italic>
###xml 1029 1033 1015 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irf7</italic>
###xml 1073 1077 1059 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gbp1</italic>
###xml 1079 1083 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gbp3</italic>
###xml 1089 1094 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdx2</italic>
###xml 1308 1310 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1384 1385 1370 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1388 1395 1374 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 1826 1828 1812 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1860 1862 1846 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1880 1882 1866 1868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 1920 1922 1906 1908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 1947 1949 1933 1935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 2034 2036 2020 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 2082 2084 2068 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 2087 2094 2073 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 2292 2300 2278 2282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#945;</italic>
###xml 2302 2304 2284 2286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C4</italic>
###xml 2306 2310 2288 2292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gbp1</italic>
###xml 2312 2317 2294 2299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-K1</italic>
###xml 2319 2325 2301 2307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-T2B</italic>
###xml 2327 2331 2309 2313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irf7</italic>
###xml 2333 2340 2315 2322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isgf3g,</italic>
###xml 2345 2348 2327 2330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nrl</italic>
###xml 2498 2502 2480 2484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Egr1</italic>
###xml 2504 2507 2486 2489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fos</italic>
###xml 2509 2516 2491 2495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#946;</italic>
###xml 2522 2531 2501 2506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebp&#948;</italic>
###xml 2568 2572 2543 2547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Egr1</italic>
###xml 2574 2583 2549 2554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebp&#948;</italic>
###xml 2658 2660 2629 2631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C4</italic>
###xml 2665 2674 2636 2641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebp&#948;</italic>
###xml 2725 2728 2692 2695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fos</italic>
###xml 2730 2735 2697 2702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Egr1,</italic>
###xml 2740 2749 2707 2712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebp&#948;</italic>
###xml 2822 2824 2785 2787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C4</italic>
###xml 2829 2836 2792 2796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#946;</italic>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
###xml 727 732 <span type="species:ncbi:10090">mouse</span>
###xml 1320 1325 <span type="species:ncbi:10090">mouse</span>
###xml 1373 1378 <span type="species:ncbi:10090">mouse</span>
To identify novel genes, we carefully filtered the genes that matched human RD loci to eliminate false positives, resulting in 20 potential gene candidates. These genes were ranked to focus on genes that have a low probability of falling within a region of interest by chance. To corroborate the potential for these 20 identified genes to be part of the molecular signature of photoreceptors and potentially prime candidate genes for human disease, the genes were further characterized based on their known retinal expression patterns. First, the list of genes was entered into the eye database at  to determine which genes would be correlated based on gene expression in the eye, within the BXD strains of mice along with the mouse diversity panel. Three subnetworks were identified (Table 2, column 10); a photoreceptor-specific network (Pla2g7, Gnb1, Pde6beta, Vtn, and Nrl), transcription factors (Fos, Egr1, and Cebpdelta), and one specific for immune-response (H2-D2, C1qbeta, C1qc, H2-K, C1qalpha, C4, H2-T23, Isgf3g, and Irf7), as well as three unassociated genes (Gbp1, Gbp3, and Prdx2). Second, to determine whether these genes were expressed in the normal photoreceptors, we examined whether they were expressed in the outer nuclear layer (rods and cones) as assessed by Blackshaw and colleagues [28] using a mouse retina  or our own quantitative RT-PCR data on mouse ONL [9] (Table 2, column 7). All but one of the genes that were identified in at least two out of three models were found to be present in the photoreceptors, for a total of 13 out of 20. Three out of 20 genes were found to be absent, and no information was available for the remaining four out of 20 genes. Third, this set of 20 genes was compared with genes identified to be misregulated under unique retinal injury conditions such as diabetes [31], ischemia-reperfusion injury [32], retinal tears [33], elevation of intraocular pressure [34], laser-induced injury [35], photoreceptor degeneration induced by a photoreceptor-specific cadherin knockout [36], as well as a model of bright-light damage [36] (Table 2, columns 8 and 9). As expected, more extensive overlap was observed with bright-light-damage-induced genes, as one of our models was the constant, low-light-induced photoreceptor cell death model (C1qalpha, C4, Gbp1, H2-K1, H2-T2B, Irf7, Isgf3g, and Nrl); however, few genes were found to overlap with the general retinal injury models (diabetes: none; ischemia-reperfusion injury: none; retinal tears: Egr1, Fos, C1qbeta, and Cebpdelta; elevation of intraocular pressure: Egr1, Cebpdelta; laser-induced injury: none) or with the photoreceptor cadherin knockout (C4 and Cebpdelta). Thus, it appears that the transcription factors Fos, Egr1, and Cebpdelta are induced during general retinal injury, as is the complement system (C4 and C1qbeta). In summary, the final list of genes should have a high potential of detecting photoreceptor-specific disease genes.
###end p 64
###begin title 65
Candidate genes for retinal disease
###end title 65
###begin p 66
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-D1</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-K</italic>
###xml 645 647 645 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C4</italic>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H2-T23</italic>
###xml 667 673 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 684 690 684 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 701 707 701 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1qc</italic>
###xml 724 730 724 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isgf3g</italic>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vtn</italic>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Egr1</italic>
###xml 768 776 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pde6&#946;</italic>
###xml 786 790 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gbp1</italic>
###xml 795 799 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gbp3</italic>
###xml 808 813 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prdx2</italic>
###xml 823 827 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irf7</italic>
###xml 906 913 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 995 998 992 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fos</italic>
###xml 1000 1007 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#946;</italic>
###xml 1009 1018 1003 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebp&#948;</italic>
###xml 1024 1028 1014 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Egr1</italic>
###xml 1127 1133 1117 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 1161 1165 1151 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1qc</italic>
###xml 1170 1174 1160 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnb1</italic>
###xml 1202 1210 1192 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#945;</italic>
###xml 1248 1251 1234 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 1288 1290 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 331 336 <span type="species:ncbi:9606">human</span>
Twenty genes passed our stringent selection criteria. Two out of the 20 genes confirmed monogenic loci associated with photoreceptor degeneration, which are typically named for the one gene carrying mutations responsible for disease (i.e., NRL and PDE6B), demonstrating that our method is able to identify previously characterized human retinal disease genes, and thus confirming the validity of our approach. Fourteen genes were identified that fell within the boundaries of the monogenic locus for which the responsible gene has already been identified, and are thus considered innocent bystanders: Locus (identified gene) TULP1 (H2-D1, H2-K, C4, H2-T23), RDS/RP7 (Pla2g7); GUCA1A (Pla2g7), GUCA1B (Pla2g7), NRL (C1qc and Isgf3g), UNC119 (Vtn), PDE6A (Egr1), MCDR2 (Pde6beta), ABCA4 (Gbp1 and Gbp3), R9AP (Prdx2), TEAD1 (Irf7). The eight remaining genes are potential candidates for mapped disease loci (Table 1). After subtracting those genes that were determined to be injury-related genes (Fos, C1qbeta, Cebpdelta, and Egr1), four potential genes remained. One of those genes was differentially expressed in three models (Pla2g7), two genes in two models (C1qc and Gnb1), and one additional gene (C1qalpha) was expressed in one of our models (rd2) and the bright-light-damage model [36]. These four genes are further discussed immediately below.
###end p 66
###begin p 67
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLA2G7</italic>
###xml 6 7 6 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pla2g7</italic>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 621 627 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLA2G7</italic>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 1295 1297 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 229 234 <span type="species:ncbi:10090">mouse</span>
PLA2G7(phospholipase A2, group VII), the top-ranked gene, is localized within the BCMAD locus, a dominant form of macular dystrophy. Pla2g7, which is expressed specifically in mouse photoreceptors, was downregulated in all three mouse models of RD. One activity of the enzyme PLA2G7 is to hydrolyze oxidized phospholipids, which are known to be generated in photoreceptors during normal light exposure. Deficiency of plasma PLA2G7 has been shown to increase the risk of vascular disease due to its antiinflammatory properties, and its ability to control levels of oxidative stress and lipid peroxidation [7]. Variants in PLA2G7 have also be found to be associated with the risk of asthma [37]. Three nonsynonymous polymorphisms appear to be associated with disease, the R92H, A379V, and I198T variants [38]. All three have decreased substrate affinity of PAF, which could prolong the half-life of this highly inflammatory protein [37]. Herein, we found that tissue and plasma levels of Pla2g7 might be differentially regulated; retinal degeneration was only associated with tissue, but not plasma levels of this enzyme. In a parallel study, we have confirmed that plasma levels of PLA2G7 appear not to be associated with a higher risk of AMD, as assessed in a population of the Rotterdam study [39].
###end p 67
###begin p 68
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNB1</italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNB1</italic>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gnb1</italic>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 806 810 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GNB1</italic>
GNB1 (guanine nucleotide binding protein, beta 1), the beta-subunit of rod-specific transducin, is localized to the LCA9 and RP32 loci. RP32, a locus for autosomal recessive retinitis pigmentosa, is located between 1p13.3 and 1p21.2, and marks a severe version of RP [40]. The LCA9 locus involved in autosomal recessive Leber congenital amaurosis, has been mapped to 1p36 by linkage mapping [41]. Gao and colleagues have recently reported an association of GNB1 intronic variants with autosomal recessive RP, as well as autosomal recessive cone-rod dystrophy [42]. On the other hand, Kitamura and colleagues have identified the Gnb1 gene as the site of mutation responsible for autosomal dominant Rd4, and have demonstrated that haploinsufficiency is the cause of disease [43]. This would tend to rule out GNB1 as the gene responsible for autosomal recessive LAC9 and RP32.
###end p 68
###begin p 69
###xml 66 74 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#945;</italic>
###xml 79 83 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1qc</italic>
###xml 498 500 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 757 759 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 880 882 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 883 885 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 886 888 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 963 965 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 966 968 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 1157 1165 1149 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C1q&#945;</italic>
###xml 1229 1232 1217 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 1240 1242 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 1362 1364 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r48">48</xref>
###xml 1112 1117 <span type="species:ncbi:10090">mouse</span>
###xml 1233 1238 <span type="species:ncbi:10090">mouse</span>
Complement component 1, q subcomponent, alpha and c polypeptides (C1qalpha and C1qc), which are upregulated in retinal degeneration, are also localized to the LCA9 and RP32 loci. C1qalpha and C1qc are part of the complement component C1q, which is an element of the classical complement pathway of innate immunity. The complement pathway is one of the major means by which the body recognizes foreign antigens and pathogens as well as tissue injury, ischemia, apoptosis, and necrosis (reviewed in [44]). However, in addition to important roles in normal host responses to self and foreign antigens, the complement system is increasingly recognized to be causally involved in tissue injury during ischemic, inflammatory and autoimmune diseases (reviewed in [45]). Recent genetic evidence has identified variations in the complement inhibitory protein factor H (also known as CFH) [14,16-18], as well as variations in the genes for complement factor B, C2, and C3 [17,46], as major risk factors for the disease. However, it is unclear how misregulation of the complement system leads to the observed pathology. In mouse models of retinal disease, eliminating C1qalpha neither alters the course of photoreceptor degeneration in the rd1 mouse [47], nor changes the development of choroidal neovascularization triggered by laser photocoagulation of Bruch's membrane [48].
###end p 69
###begin title 70
Conclusion
###end title 70
###begin p 71
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
###xml 455 463 <span type="species:ncbi:9606">patients</span>
###xml 545 550 <span type="species:ncbi:10090">mouse</span>
We have shown that the comparative genomics approach verified existing RD genes as well as identified novel RD candidate genes. This approach may be useful for focusing the search for novel genes in both RD and other diseases for which there are appropriate mouse animal models. Further studies are now needed to provide more evidence of the functionality, role, and relevance of these genes. Those studies should include sequencing of the human genes in patients with the appropriate diagnosis as well as the generation of appropriate knockout mouse strains, or elimination/activation of the targeted gene or pathway by pharmacological or molecular means. We hope to test these and other hypotheses that were generated in an unbiased and rational strategy that we systematically developed in this report.
###end p 71
###begin title 72
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Appendix 1:</bold>
###xml 72 79 72 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
Appendix 1: Experimental data on which the selection of genes listed in Table 1 of the manuscript is based.
###end title 72
###begin p 73
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 343 346 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd1</italic>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 553 555 553 555 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 720 723 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rd1</italic>
###xml 779 782 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd2</italic>
###xml 999 1006 995 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1113 1120 1109 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1125 1132 1121 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 408 413 <span type="species:ncbi:10090">mouse</span>
A: Gene expression data for genes that are differentially regulated in the three mouse models of retinal dystrophy-rd1 mouse, rd2 mouse, and light-damage (LD) in the albino mouse-as identified by DChip analysis. Gene expression data for the experimental and control group at the two experimental time points are listed as follows: columns 2-5 rd1 mouse at postnatal days 6 and 10 (P6, P10); columns 8-11 rd2 mouse, P14, and P21; and columns 14-17 BALB/c control and BALB/c LD at 24 h and 48 h of LD. Each value represents the average of two replicates. B: Differences in gene expression levels (fold change) and respective difference of the mean (Delta mean) between experimental retinas and their age-matched controls. Rd1 retinas were analyzed from postnatal day (P) P6, P10], rd2 retinas from P14, P21, and light-damaged retinas (LD) after 24 and 48 h of light exposure. Gene expression analysis contains procedures for strong control of false discovery rate (FDR). As indicated in the legend to Table 1, the Affymetrix Gene ID and the gene symbol represents the common denominator for table identification in Table 1 and Table 2 as well as , and .
###end p 73
###begin title 74
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Appendix 2:</bold>
Appendix 2: Gene ontology analysis for differentially regulated genes found in unsolved locations.
###end title 74
###begin p 75
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
Gene ontology terms that are associated with the differentially regulated genes found in unsolved locations (tabulated in Table 1-i.e., experimental list) were analyzed. Over-represented terms for the biologic processes describing these identified genes were determined by comparing them with the reference genes (i.e., all the genes present on the entire array minus the experimental list). The top GO identifications (GO ID; column 1) and GO terms (column 2) are listed to characterize as many genes possible with significant GO terms. The genes represented by those GO terms (column 3), as well as the corresponding p-values (column 4) are listed.
###end p 75
###begin title 76
Acknowledgments
###end title 76
###begin p 77
Funding was provided by National Institutes of Health (NIH) / National Eye Institute grants EY-13520 (B.R.) and vision core EY-14793; the Karl Kirchgessner Foundation (B.R.); and an unrestricted grant to Medical University of South Carolina from Research to Prevent Blindness (RPB), Inc.. B.R. is a RPB Olga Keith Weiss Scholar. The Medical University of South Carolina microarray facility is supported by NIH/National Center for Research Resources South Carolina Center of Biomedical Research Excellence for Cardiovascular Disease (RR-16434), and a National Cancer Institute Shared Resource grant (R24 CA95841). The MUSC animal facility was completed with the help of a NIH construction grant (C06 RR015455). We thank Michael Danciger for helpful discussions throughout the project, Katie Hulse, Yao Guo, and Heather Lohr for generating the microarray data, Adam Richards and Drs. Paul Nietert for assistance with statistical algorithms, and Luanna Bartholomew for critical review.
###end p 77
###begin title 78
References
###end title 78
###begin article-title 79
Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions.
###end article-title 79
###begin article-title 80
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 13 16 <span type="species:ncbi:9606">men</span>
From mice to men: the cyclic GMP phosphodiesterase gene in vision and disease. The Proctor Lecture.
###end article-title 80
###begin article-title 81
Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds).
###end article-title 81
###begin article-title 82
Lack of p75 receptor does not protect photoreceptors from light-induced cell death.
###end article-title 82
###begin article-title 83
Lifespan and mitochondrial control of neurodegeneration.
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
###end article-title 84
###begin article-title 85
Oxidized phospholipids: emerging lipid mediators in pathophysiology.
###end article-title 85
###begin article-title 86
Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death.
###end article-title 86
###begin article-title 87
Current concepts in the pathogenesis of age-related macular degeneration.
###end article-title 87
###begin article-title 88
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.
###end article-title 88
###begin article-title 89
Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.
###end article-title 89
###begin article-title 90
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration.
###end article-title 90
###begin article-title 91
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 91
###begin article-title 92
###xml 136 153 <span type="species:ncbi:9541">cynomolgus monkey</span>
###xml 155 174 <span type="species:ncbi:9541">Macaca fascicularis</span>
Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis).
###end article-title 92
###begin article-title 93
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 93
###begin article-title 94
AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.
###end article-title 94
###begin article-title 95
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 95
###begin article-title 96
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Cyclic guanosine monophosphate: elevation in degenerating photoreceptor cells of the C3H mouse retina.
###end article-title 96
###begin article-title 97
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Multidestructive pathways triggered in photoreceptor cell death of the rd mouse as determined through gene expression profiling.
###end article-title 97
###begin article-title 98
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa.
###end article-title 98
###begin article-title 99
The efficiency of pooling mRNA in microarray experiments.
###end article-title 99
###begin article-title 100
Role of neurotrophin receptor TrkB in the maturation of rod photoreceptors and establishment of synaptic transmission to the inner retina.
###end article-title 100
###begin article-title 101
PAX genes.
###end article-title 101
###begin article-title 102
Calcium overload triggers rod photoreceptor apoptotic cell death in chemical-induced and inherited retinal degenerations.
###end article-title 102
###begin article-title 103
The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane-associated glycoprotein.
###end article-title 103
###begin article-title 104
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Genomic analysis of mouse retinal development.
###end article-title 104
###begin article-title 105
Pathways to photoreceptor cell death in inherited retinal degenerations.
###end article-title 105
###begin article-title 106
The Retinome - defining a reference transcriptome of the adult mammalian retina/retinal pigment epithelium.
###end article-title 106
###begin article-title 107
Expression of acute-phase response proteins in retinal Muller cells in diabetes.
###end article-title 107
###begin article-title 108
Differential temporal and spatial expression of immediate early genes in retinal neurons after ischemia-reperfusion injury.
###end article-title 108
###begin article-title 109
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Temporal changes in gene expression after injury in the rat retina.
###end article-title 109
###begin article-title 110
###xml 53 56 <span type="species:ncbi:10116">rat</span>
Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure.
###end article-title 110
###begin article-title 111
Argon laser photocoagulation-induced modification of gene expression in the retina.
###end article-title 111
###begin article-title 112
The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia.
###end article-title 112
###begin article-title 113
The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma.
###end article-title 113
###begin article-title 114
Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.
###end article-title 114
###begin article-title 115
Severe autosomal recessive retinitis pigmentosa maps to chromosome 1p13.3-p21.2 between D1S2896 and D1S457 but outside ABCA4.
###end article-title 115
###begin article-title 116
Identification of a locus (LCA9) for Leber's congenital amaurosis on chromosome 1p36.
###end article-title 116
###begin article-title 117
Association of the Asn306Ser variant of the SP4 transcription factor and an intronic variant in the beta-subunit of transducin with digenic disease.
###end article-title 117
###begin article-title 118
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Disruption of the gene encoding the beta1-subunit of transducin in the Rd4/+ mouse.
###end article-title 118
###begin article-title 119
The complement system and adaptive immunity.
###end article-title 119
###begin article-title 120
The complement system as a therapeutic target in autoimmunity.
###end article-title 120
###begin article-title 121
Complement C3 variant and the risk of age-related macular degeneration.
###end article-title 121
###begin article-title 122
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse.
###end article-title 122
###begin article-title 123
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H.
###end article-title 123

